Luca Boscolo Bielo

Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer

Luca Cantini, Dario Trapani, Lorenzo Guidi et al. · Cancer Treatment Reviews · 2023 · 36 citations

Breast Oncology, Neoadjuvant Therapy, Medicine +4

Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience

Matteo Repetto, Edoardo Crimini, Luca Boscolo Bielo et al. · European Journal of Cancer · 2023 · 25 citations

Year Activity, Tumoral Pathology, European Institute +10

Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact

Konstantinos Venetis, Chiara Frascarelli, Luca Boscolo Bielo et al. · European Journal of Cancer · 2025 · 19 citations

The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer

Luca Boscolo Bielo, Dario Trapani, Eleonora Nicolò et al. · Cancer Treatment Reviews · 2024 · 17 citations

Breast Oncology, Endocrine-related Cancer, Medicine +8

Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial

D. Ciardiello, Luca Boscolo Bielo, S. Napolitano et al. · Annals of Oncology · 2024 · 17 citations · Full text